SCM
AGN

Sarissa Capital Management’s Allergan plc AGN Stock Holding History

Sarissa Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-467,500
Closed -$82.8M – 13
2020
Q1 		$82.8M Hold
467,500
– – 10.56% 4
2019
Q4 		$89.4M Sell
467,500
-575,000
-55% -$104M 7.42% 5
2019
Q3 		$175M Hold
1,042,500
– – 21.99% 2
2019
Q2 		$175M Buy
1,042,500
+174,500
+20% +$24.2M 21.76% 1
2019
Q1 		$127M Buy
868,000
+321,500
+59% +$46.6M 19.13% 1
2018
Q4 		$73M Buy
546,500
+202,500
+59% +$33.2M 16.19% 3
2018
Q3 		$65.5M Hold
344,000
– – 14.45% 3
2018
Q2 		$57.4M Hold
344,000
– – 11.5% 5
2018
Q1 		$57.9M Buy
344,000
+86,700
+34% +$14.5M 13.4% 4
2017
Q4 		$42.1M Buy
+257,300
New +$46.2M 10.77% 5

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Sarissa Capital Management's AGN Position: Q2 2020 in Review

Sarissa Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 467,500 shares — an estimated $82.8M sold.

Sarissa Capital Management first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $175M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Sarissa Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Sarissa Capital Management sold 467,500 Allergan plc shares in Q2 2020, an estimated $82.8M.
  • Sarissa Capital Management first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • Sarissa Capital Management's Allergan plc position peaked at $175M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Sarissa Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.